Literature DB >> 23773004

A method for conducting functional MRI studies in alert nonhuman primates: initial results with opioid agonists in male cynomolgus monkeys.

Marc J Kaufman1, Amy C Janes, Blaise deB Frederick, Melanie Brimson-Théberge, Yunjie Tong, Samuel B McWilliams, Ashley Bear, Timothy E Gillis, Katrina M Schrode, Perry F Renshaw, S Stevens Negus.   

Abstract

Functional MRI (fMRI) has emerged as a powerful technique for assessing neural effects of psychoactive drugs and other stimuli. Several experimental approaches have been developed to use fMRI in anesthetized and awake animal subjects, each of which has its advantages and complexities. We sought to assess whether one particular method to scan alert postanesthetized animals can be used to assess fMRI effects of opioid agonists. To date, the use of fMRI as a method to compare pharmacological effects of opioid drugs has been limited. Such studies are important because mu and kappa opioid receptor agonists produce distinct profiles of behavioral effects related both to clinically desirable endpoints (e.g., analgesia) and to undesirable effects (e.g., abuse potential). This study sought to determine whether we could use our fMRI approach to compare acute effects of behaviorally equipotent (3.2 μg/kg) intravenous doses of fentanyl and U69,593 (doses that do not affect cardiorespiratory parameters). Scans were acquired in alert male cynomolgus macaques acclimated to undergo fMRI scans under restraint, absent excessive stress hormone increases. These opioid agonists activated bilateral striatal and nucleus accumbens regions of interest. At the dose tested, U69,593 induced greater left nucleus accumbens BOLD activation than fentanyl, while fentanyl activated left dorsal caudate nucleus more than U69,593. Our results suggest that our fMRI approach could be informative for comparing effects of opioid agonists. PsycINFO Database Record (c) 2013 APA, all rights reserved

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23773004      PMCID: PMC3916219          DOI: 10.1037/a0033062

Source DB:  PubMed          Journal:  Exp Clin Psychopharmacol        ISSN: 1064-1297            Impact factor:   3.157


  50 in total

1.  Psychotomimesis mediated by kappa opiate receptors.

Authors:  A Pfeiffer; V Brantl; A Herz; H M Emrich
Journal:  Science       Date:  1986-08-15       Impact factor: 47.728

Review 2.  Anatomy of CNS opioid receptors.

Authors:  A Mansour; H Khachaturian; M E Lewis; H Akil; S J Watson
Journal:  Trends Neurosci       Date:  1988-07       Impact factor: 13.837

3.  Place preference conditioning reveals the involvement of D1-dopamine receptors in the motivational properties of mu- and kappa-opioid agonists.

Authors:  T S Shippenberg; A Herz
Journal:  Brain Res       Date:  1987-12-08       Impact factor: 3.252

4.  Dynorphin agonist therapy of Parkinson's disease.

Authors:  M Giuffra; M M Mouradian; T L Davis; J Ownby; T N Chase
Journal:  Clin Neuropharmacol       Date:  1993-10       Impact factor: 1.592

5.  Antagonism of the analgesic effects of mu and kappa opioid agonists in the squirrel monkey.

Authors:  L A Dykstra; C A Massie
Journal:  J Pharmacol Exp Ther       Date:  1988-09       Impact factor: 4.030

6.  Evidence that the aversive effects of opioid antagonists and kappa-agonists are centrally mediated.

Authors:  R Bals-Kubik; A Herz; T S Shippenberg
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

7.  Cardiovascular, respiratory, and analgesic effects of fentanyl in unanesthetized rhesus monkeys.

Authors:  N A Nussmeier; J L Benthuysen; E P Steffey; J H Anderson; E E Carstens; J H Eisele; T H Stanley
Journal:  Anesth Analg       Date:  1991-02       Impact factor: 5.108

8.  Motivational properties of kappa and mu opioid receptor agonists studied with place and taste preference conditioning.

Authors:  R F Mucha; A Herz
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

9.  The effects of opioid peptides on dopamine release in the nucleus accumbens: an in vivo microdialysis study.

Authors:  R Spanagel; A Herz; T S Shippenberg
Journal:  J Neurochem       Date:  1990-11       Impact factor: 5.372

10.  Aversive and appetitive properties of anxiogenic and anxiolytic agents.

Authors:  S E File
Journal:  Behav Brain Res       Date:  1986-09       Impact factor: 3.332

View more
  4 in total

1.  Convergent Balancing Selection on the Mu-Opioid Receptor in Primates.

Authors:  Carolyn G Sweeney; Juliette M Rando; Helen N Panas; Gregory M Miller; Donna M Platt; Eric J Vallender
Journal:  Mol Biol Evol       Date:  2017-07-01       Impact factor: 16.240

2.  Fentanyl-induced changes in brain activity in awake nonhuman primates at 9.4 Tesla.

Authors:  Sarah L Withey; Lei Cao; Fernando B de Moura; Kenroy R Cayetano; Michael L Rohan; Jack Bergman; Stephen J Kohut
Journal:  Brain Imaging Behav       Date:  2022-02-28       Impact factor: 3.224

Review 3.  Applications in Awake Animal Magnetic Resonance Imaging.

Authors:  Craig F Ferris
Journal:  Front Neurosci       Date:  2022-04-05       Impact factor: 5.152

4.  A functional polymorphism in the prodynorphin gene affects cognitive flexibility and brain activation during reversal learning.

Authors:  Mikhail Votinov; Juergen Pripfl; Christian Windischberger; Ewald Moser; Uta Sailer; Claus Lamm
Journal:  Front Behav Neurosci       Date:  2015-07-03       Impact factor: 3.558

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.